Osmotically controlled drug delivery system with associated drugs

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 4, 2010, Pages 571-588

  Gupta, Brahma P ^a   Thakur, Navneet ^a   Jain, Nishi P ^a   Banweer, Jitendra ^a   Jain, Surendra ^a  

^a Sagar Institute of Research and Technology Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRESS LP; CARBAMAZEPINE; CHLORPHENIRAMINE MALEATE; CHLORPROMAZINE; DILTIAZEM; DOXAZOSIN; EFIDAC 24; GLIPIZIDE; ISRADIPINE; LEUPRORELIN; METHYLPHENIDATE; METOPROLOL; NIFEDIPINE; OSMOTIC AGENT; OXPRENOLOL; OXYBUTYNIN; PALIPERIDONE; PHENYLPROPANOLAMINE; PLASTICIZER; PRAZOSIN; PSEUDOEPHEDRINE; SALBUTAMOL SULFATE; SOLVENT; SUDAFED 24; SUFENTANIL; TRAMADOL; UNCLASSIFIED DRUG; VERAPAMIL;

ANGINA PECTORIS; ATTENTION DEFICIT DISORDER; BRONCHOSPASM; CONTROLLED DRUG RELEASE; DELAYED DRUG RELEASE; DIFFUSION; DRUG CAPSULE; DRUG COATING; DRUG FORMULATION; EPIPHORA; GASTROINTESTINAL ABSORPTION; HUMAN; HYPERTENSION; MEMBRANE PERMEABILITY; NARCOLEPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OCULAR PRURITUS; OSMOSIS; OSMOTIC PRESSURE; OSMOTIC PUMP; OVERACTIVE BLADDER; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRURITUS; PULSATILE DRUG RELEASE; RASH; REVIEW; RHINORRHEA; SCHIZOPHRENIA; SINUS PAIN; SOLUBILITY; TABLET COMPRESSION;

EID: 78650315524     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j38w25     Document Type: Review

References (52)

1. Madhavi BB, Nath AR, Banji D, Ramalingam R, Madhu MN, Kumar DS. Osmotic drug delivery system: a review. Pharmakine, dec 2009;2:5-14.
2. Prescott, L.F, The need for improved drug delivery in clinical practice, in: Prescott LF, Nimmo WS (eds), Novel Drug Delivery and Its Therapeutic Application, John Wiley, UK, pp 1-11, 1989.
3. Sastry SV, DeGennaro MD, Reddy IK, Khan MA. Atenolol gastrointestinal therapeutic system Part 1: Screening of formulation variables. Drug Dev Ind Pharm 1997; 23: 2:157-165.
4. Mishra B, Makesh BK, Sankar C. Oral push-pull osmotic pumps of pentazocine hydrochloride: development and evaluation. Ind J Pharm Sci, 2006; 68:1:85-87.
5. Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release, 2002; 79:7-27
6. YANG Xing-Gang, ZHANG Guo-Hua, LI Wei, PENG Bo, LIU Zhi-Dong, PAN Wei-San. Design and Evaluation of Jingzhiguanxin Monolithic Osmotic Pump Tablet. Chem Pharm Bull, 2006; 54: 4:465-469.
7. Makhija Sapna N, Vavia Pradeep R. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I: Cellulose acetate as a semipermeable membrane. J Control Release, 2003; 89:5-18
8. Srikonda Sastry, Kotamraj Phanidhar, Barclay Brian, Osmotic controlled drug delivery system, in Li Xiaoling, Jasti Bhaskara R (eds), Design of Controlled Release Drug Delivery Systems, McGraw-Hill Companies, INC, New York, pp 203-229,2006
9. McClelland GA, Sulton SC, Engle K, Zentner GM. The solubility-modulated osmotic pump: invitro /invivo release of diltiazem hydrochloride. Pharma Res 1991; 8:88-92.
10. Rose S, Nelson JF. A continuous long-term injector. Aust J Exp Biol, 1955; 33:415
11. Higuchi T, Leeper HM. Improved osmotic dispenser employing magnesium sulfate and magnesium chloride. US Patent 3760804, 1973.
12. Higuchi T, Leeper HM. Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient. US Patent 3995631, 1976.
13. Theeuwes, F. Elementary Osmotic Pump. J Pharm Sci, 1975; 64:1987-1991.
14. Kaushal AM, Garg S. An update on osmotic drug delivery patents. Pharm Tech, Aug 2003; 27:38-44.
15. Bhatt PP. Osmotic drug delivery systems for poorly soluble drugs. The drug delivery companies report autumn/winter 2004.
16. Parmar NS, Vyas SK, jain NK. Advances in controlled and novel drug delivery. CBS publisher & distributors, New Delhi, pp 18-39, 2001.
17. Eckenhoff, Yum SI. The osmotic pump: novel research tool for optimizing drug regimen. Biomaterials, 1981; 2:89-97
18. Good WR, Lee PI. Membrane-controlled reservoir drug delivery systems, in Langer RS, Wise DL (eds), Medical Applications of Controlled Release, I Vol., Boca Raton, CRC Press, pp 1-39, 1984.
19. Theeuwes F, Higuchi T. Osmotic dispensing device with maximum and minimum sizes for the passageway. US Patent 3916899, 1975.
20. Gaebler, F. Laser drilling enables advanced drug delivery systems. Coherent article for Pharm Manufacturing, Jan 2007;1-7.
21. Theeuwes F, Saunders RJ, Mefford WS. Process for forming outlet passageways in pills using a laser. US Patent 4088864; 1978.
22. Liu L, Wang X. Solubility modulated monolithic osmotic pump tablet for atenolol delivery. Eur J Pharm Biopharm 2008; 68: 2:298-302.
23. Khanna, SC. Therapeutic system for sparingly soluble active ingredients. Ciba-Geigy Corporation, Ardsley, NY, US Patent 4992278, 1997.
24. Zentner GM, McClelland GA, Sutton SC. Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride. J Control Release, 1991; 16:1-2:237-243.
25. Okimoto K, Ohike A, Ibuki R, et al. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone: a poorly water soluble drug using (SBE)7m-beta-CD. Pharm Res, 1998; 15: 10:1562-1568.
26. Theeuwes F, Swanson DR, Guittard G, et al. Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: Design and evaluation of systems for once-daily administration. Br J Clin Pharmacol, 1985;19: 2:69S-76S.
27. Santus G, Baker RW. Osmotic drug delivery: A review of the patent literature. J Control Release, 1995;35: 1:1-21.
28. Eckenhoff B, Theeuwes F, Urquhart J. Osmotically actuated dosage forms for rate-controlled drug delivery. Pharm Technol 1987; 11:96-105.
29. Jensen JL, Appel LE, Clair JH, Zentner GM. Variables that affect the mechanism of drug release from osmotic pumps coated withacrylate/methacrylate copolymer latexes. J Pharm Sci, 1995; 84: 5:530-533.
30. Vyas, S.P.; Khar, R.K., Controlled drug delivery: concept and advances. Vallabh prakashan, New Delhi, pp 477-501, 2001.
31. Theeuwes F, Swanson D, Wong P, Bonsen P, Place V, Heimlich K, Kwan KC. elementary osmotic pump for indometacin. J pharm Sci 1983; 72:253-258.
32. Liu L, Ku J, Khang G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Release, 2000; 68:145-156.
33. Haslem J, Rork GS. Controlled porosity osmotic pump. US Patent 488063, 1989.
34. Thombrea AG, Cardinall JR, DeNoto AR, Herbig SM, Smith KL. Asymmetric membrane capsules for osmotic drug delivery: Development of a manufacturing process. J Control Release, 1999; 57:55-64.
35. Zentner GM, Rork GS, Himmelsteine KJ. Osmotic flow through controlled porosity films: an approach to deliver water soluble compounds. J Control Release, 1985; 2:217-229.
36. Theuwes, F.; Wong, P.S.L.; Burkoth, T.L.; Fox, D.A.; Bicek, P.R., Colonic drug absorption and metabolism. Marcel Decker, New York, pp 137-158, 1993.
37. Conley R, Gupta SK, Satyan G. Clinical spectrum of the osmotic controlled release oral delivery system (OROS): an advanced oral delivery form. Current medical research and opinion, 2006; 22:1879-1892.
38. Arora S, Ali J, Ahuja A, Baboota S, Qureshi J. Pulsatile drug delivery systems: An approach for controlled drug delivery. Ind J Pharm Sci, 2006; 68: 3:295-300.
39. Malaterre V, Metz H, Ogorka J, Mader K, Gurny R, Loggia N. Influence of the hydration kinetics and the viscosity balance on the drug release performance of push-pull osmotic systems. Novartis Pharma AG, Technical R&D, Fabrikstrasse 2, CH- 4056 Basel, Switzerland, 1-2.
40. Wright JD, Barelay BL, Swanson DR. International Patent, WO 92/18102
41. Herbig SM, Cardinal JR, Korsmeyer KL, Smith KL. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Control Release, 1995; 35:127-136.
42. Nagakura T, Ishihara K, Furukawa T, Masuda K, Tsuda T. Auto-regulated Osmotic pump for insulin therapy by sensing glucose concentration without energy supply. Sensors and Actuators B, 1996; 34: 229-233.
43. Roger RA, et al. Factors affecting membrane controlled drug release for an osmotic pump tablet utilizing (SBE)7m --CD as both a solubilizer and osmotic agent. J Control Release, 1999; 60:311-319.
44. Lee HB, Liu L, Ku J, Khang G, Lee B, Rhee JM. Nifedipine controlled delivery sandwiched osmotic tablet system. J Control Release, 2000; 68:145-156.
45. Roger RA, et al. Applicability of (SBE)7m --CD in controlled-porosity osmotic pump tablets (OPTs). Int J Pharm, 2004; 286:81-88.
46. Choudhury PK, Ranawat MS, Pillai MK, Chauhan CS. Asymmetric membrane capsule for osmotic delivery of flurbiprofen. Acta Pharm, 2007; 57:343-350.
47. Liu L, Xu X. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet. Int J Pham, 2008; 352: 1-2:225-230.
48. Philip AK, Pathak K. In situ formed phase transited drug delivery system of ketoprofen for achieving osmotic controlled and level a in vitro in vivo correlation. Ind J pharm Sci, 2008; 70: 6:745-753.
49. Mahalaxmi R, Sastri P, kumar R, Kalra A, Kanagale P, Narkhede. Enhancement of Dissolution of Glipizide from Controlled Porosity Osmotic Pump Using a Wicking Agent and a Solubilizing Agent. Int J PharmTech Res, 2009; 1: 3:705-711.
50. Kumar Pramod, Singh Sanjay, Mishra Brahmeshwar. Development and Evaluation of Elementary Osmotic Pump of Highly Water Soluble Drug: Tramadol Hydrochloride. Current Drug Delivery, 2009; 6:130-139.
51. Rajeshri Wakode, Varma MM. Once a day osmotic drug delivery system for highly water soluble Pramipexole. J Chem Pharm Res, 2010; 2: 2:136-146.
52. Mothilal M, Damodharan N, Lakshmi KS, Sharanya VB, Srikrishna T. Formulation and invitro evaluation of osmotic drug delivery system of metoprolol succinate. Int J Pharm Pharm Sci, 2010; 2: 2:64-68.